Table 1.
Primary antibodies being employed for immunoblotting.
| Antigen | Antibody | Source | Reference |
|---|---|---|---|
| Tenascin-C, monoclonal | B28.13 | Prof. Chiquet | Hughes et al., 1999 |
| MyoD | C20 sc-304 | Santa Cruz | Li et al., 2013 |
| Myogenin | F5D sc-12732 | Santa Cruz | Li et al., 2013 |
| NDUFA9, monoclonal | 20C11B11B11 | Invitrogen | Andersen et al., 2000 |
| SDHA, monoclonal | 2E3GC12FB2AE2 | Invitrogen | Andersen et al., 2000 |
| UQCRC1, monoclonal | 13G12AF12BB11 | Invitrogen | Andersen et al., 2000 |
| COX4I1, monoclonal | 20E8C12 | Invitrogen | Andersen et al., 2000 |
| ATP5A1, monoclonal | 15H4C4 | Invitrogen | Andersen et al., 2000 |
| Sarcomeric actin, monoclonal | A2172 | Sigma | Andersen et al., 2000 |
| C-terminal FAK | Prof. Ziemiecki | van Yperen et al., 2018 | |
| N-terminal FAK | AF4467 | R&D systems | |
| pY397FAK | P00151 | Boster Biological Technology | |